Keyphrases
Acute Myocardial Infarction
100%
C1 Esterase Inhibitor
100%
Contact System
100%
FXIa
75%
FXIIa
50%
Kallikrein
37%
Acute Phase
25%
Arterial Thrombosis
25%
Recurrent Events
25%
Antitrypsin
25%
One Year Period
12%
Contact Activation
12%
Acute Events
12%
Recurrent Cardiovascular Events
12%
Enzyme-inhibitor Complex
12%
Alpha-1 Antitrypsin
12%
Activated Factor XI
12%
INIS
patients
100%
myocardial infarction
100%
esterases
100%
levels
87%
kallikrein
37%
thrombosis
25%
plasma
25%
comparative evaluations
12%
enzyme inhibitors
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
100%
Complement Component C1s Inhibitor
100%
Kallikrein
37%
Artery Thrombosis
25%
Trypsin Inhibitor
25%
Clinical Study
12%
Enzyme Inhibitor
12%
Blood Clotting Factor 11
12%
Alpha 1 Antitrypsin
12%
Biochemistry, Genetics and Molecular Biology
C1-Inhibitor
100%
Kallikrein
37%
Blood Plasma
25%
Alpha 1-Antitrypsin
12%
Clinical Study
12%
Factor XI
12%
Enzyme Inhibitor Complex
12%
Immunology and Microbiology
C1-Inhibitor
100%
Blood Plasma
25%
Alpha 1-Antitrypsin
12%
Enzyme Inhibitor Complex
12%